文献速递乳腺US

提升乳腺癌诊断:整合人工智能超声与临床因素的列线图模型

Enhancing Breast Cancer Diagnosis: A Nomogram Model Integrating AI Ultrasound and Clinical Factors.
PubMed 文献 · Ultrasound Med Biol · 2024-06-19

本研究分析308例患者共340个乳腺肿块的超声资料,按260个训练、80个验证分组,基于S-detect人工智能系统构建仅含AI结果的AI列线图与加入年龄、AI肿块大小和AI诊断的ClinAI列线图。ClinAI列线图在训练组AUC为0.873、验证组为0.847,均显著高于AI列线图的0.792和0.770,校准曲线显示预测概率与实际恶性风险高度一致。

要点

  • ClinAI列线图整合患者年龄、AI肿块大小和AI诊断,训练组AUC 0.873,验证组AUC 0.847。
  • AI列线图训练组AUC 0.792、验证组AUC 0.770,ClinAI列线图预测恶性均显著更优。
  • 校准曲线显示ClinAI列线图预测概率与实际观察恶性风险高度一致。

核心结论

  • 整合人工智能结果与临床数据的ClinAI列线图,在AI辅助超声检查中显著提升乳腺良恶性肿块的鉴别能力。

研究设计与样本

  • 研究分析308例患者经超声检出的340个乳腺肿块,分为训练组260个和验证组80个;AI分析采用Samsung Ultrasound AI系统(S-detect),用单因素和多因素逻辑回归构建列线图。

诊断标准与关键数值

  • AI列线图仅基于AI结果,ClinAI列线图纳入患者年龄、AI肿块大小和AI诊断;训练组AUC 0.873(95%CI 0.830-0.917)vs AI列线图0.792(95%CI 0.748-0.836),p=0.016;验证组AUC 0.847(95%CI 0.763-0.932)vs AI列线图0.770(95%CI 0.709-0.833),p<0.001。

临床应用与阅片要点

  • 作者认为ClinAI列线图整合AI与临床数据,可显著提升临床AI辅助超声检查中乳腺良恶性肿块的鉴别。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: A novel nomogram incorporating artificial intelligence (AI) and clinical features for enhanced ultrasound prediction of benign and malignant breast masses.

MATERIALS AND METHODS: This study analyzed 340 breast masses identified through ultrasound in 308 patients. The masses were divided into training (n = 260) and validation (n = 80) groups. The AI-based analysis employed the Samsung Ultrasound AI system (S-detect). Univariate and multivariate analyses were conducted to construct nomograms using logistic regression. The AI-Nomogram was based solely on AI results, while the ClinAI- Nomogram incorporated additional clinical factors. Both nomograms underwent internal validation with 1000 bootstrap resamples and external validation using the independent validation group. Performance was evaluated by analyzing the area under the receiver operating characteristic (ROC) curve (AUC) and calibration curves.

RESULTS: The ClinAI-Nomogram, which incorporates patient age, AI-based mass size, and AI-based diagnosis, outperformed an existing AI-Nomogram in differentiating benign from malignant breast masses. The ClinAI-Nomogram surpassed the AI-Nomogram in predicting malignancy with significantly higher AUC scores in both training (0.873, 95% CI: 0.830-0.917 vs. 0.792, 95% CI: 0.748-0.836; p = 0.016) and validation phases (0.847, 95% CI: 0.763-0.932 vs. 0.770, 95% CI: 0.709-0.833; p < 0.001). Calibration curves further revealed excellent agreement between the ClinAI-Nomogram's predicted probabilities and actual observed risks of malignancy.

CONCLUSION: The ClinAI- Nomogram, combining AI alongside clinical data, significantly enhanced the differentiation of benign and malignant breast masses in clinical AI-facilitated ultrasound examinations.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Yu ZH, Hong YT, Chou CP, et al. Enhancing Breast Cancer Diagnosis: A Nomogram Model Integrating AI Ultrasound and Clinical Factors. Ultrasound Med Biol. 2024. PMID: 38897841. doi:10.1016/j.ultrasmedbio.2024.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。